TAIHO PHARMA

We strive to
improve human
health and contribute
to a society enriched
by smiles

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Releases

April 16, 2018

Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy（PDF：40.5 KB）
March 13, 2018

Taiho Pharmaceutical Announces Personnel Changes（PDF：63.3 KB）
March 07, 2018

Health Canada Approves LONSURF^® (trifluridine/tipiracil) for Metastatic Colorectal Cancer
February 21, 2018

Taiho Pharmaceutical Recognized as White 500 for Outstanding Health and Productivity Management
January 19, 2018

Otsuka Holdings Signs Statement of Support for Women's Empowerment Principles（PDF：189.9 KB）